Annexon Q2 FY26 net loss widens to $55.35 million
Reuters2026/08/12 10:15- Annexon posted a Q2 net loss attributable to common stockholders of USD 55.35 million, or USD 0.28 per share.
- RD expense rose to USD 46.59 million from USD 44.16 million a year earlier, on Phase 3 ARCHER II and manufacturing costs.
- GA costs climbed to USD 10.64 million from USD 7.57 million, reflecting higher consulting and professional services.
- Cash, cash equivalents and short-term investments totaled USD 209.2 million at June 30; runway expected to extend into 2028.
- Tanruprubart BLA filing targeted for Q4 2026; vonaprument Month 15 primary endpoint due Q4 2026, Month 24 completion Q3 2027.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Community Reacts As Pundit Claims XRP Will Be Priced At $2,953 By Q2 2027
Colgate-Palmolive (CL.US) plans to sell part of its personal care brands, with a total transaction amount possibly exceeding 1.1 billions USD.
According to sources familiar with the matter, Colgate is exploring the sale of some of its mass-market personal care brands. The company currently plans to divest only a few brands within its personal care business, and the combined sale price may exceed 1 billion dollars.
EdiliziAcrobatica announces shareholder meeting notice
Crypto prices
More
